Niino Masaaki
Department of Clinical Research, Hokkaido Medical Center, Nishi-ku, Sapporo, Japan.
Drugs Today (Barc). 2010 Apr;46(4):279-90. doi: 10.1358/dot.2010.46.4.1476498.
Mapping the distribution of multiple sclerosis (MS) reveals a high prevalence of the disease in high-latitude areas, suggesting a positive relationship between vitamin D and MS. Vitamin D is known to play an important role in bone and mineral homeostasis. It has recently been reported that several types of immune cells express vitamin D receptors and that vitamin D has strong immune-modulating effects. Vitamin D and its analogues inhibited experimental autoimmune encephalomyelitis (EAE, an animal model of MS) and there have been reports of small clinical trials on the treatment of MS with vitamin D. Furthermore, there have been discussions on the association between vitamin D levels and MS and about the genetic risk of vitamin D receptor (VDR) gene polymorphisms in MS. The current review discusses the immunological functions of vitamin D, the association between vitamin D and MS and expectations regarding the role of vitamin D in future treatments of MS.
绘制多发性硬化症(MS)的分布图显示,该疾病在高纬度地区的患病率很高,这表明维生素D与MS之间存在正相关关系。众所周知,维生素D在骨骼和矿物质稳态中起重要作用。最近有报道称,几种免疫细胞表达维生素D受体,并且维生素D具有强大的免疫调节作用。维生素D及其类似物可抑制实验性自身免疫性脑脊髓炎(EAE,MS的动物模型),并且有关于用维生素D治疗MS的小型临床试验的报道。此外,还讨论了维生素D水平与MS之间的关联以及MS中维生素D受体(VDR)基因多态性的遗传风险。本综述讨论了维生素D的免疫功能、维生素D与MS之间的关联以及对维生素D在MS未来治疗中作用的期望。